Entity Common Stock, Shares Outstanding of AXIM BIOTECHNOLOGIES, INC. from 15 Nov 2011 to 16 Aug 2024

Taxonomy & unit: dei: shares
Description: Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary: AXIM BIOTECHNOLOGIES, INC. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 15 Nov 2011 to 16 Aug 2024.
AXIM BIOTECHNOLOGIES, INC. Entity Common Stock, Shares Outstanding for the quarter ending 16 Aug 2024 was 301,958,824, a 27% increase year-over-year.
Source SEC data: View on sec.gov

Entity Common Stock, Shares Outstanding, Quarterly (shares)

Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

AXIM BIOTECHNOLOGIES, INC. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2024	301,958,824	+64,309,421	+27%	16 Aug 2024	10-Q	19 Aug 2024	2024	Q2
Q2 2024	291,458,824	+63,809,421	+28%	20 May 2024	10-Q/A	22 May 2024	2024	Q1
Q1 2024	278,429,403	+54,780,000	+24%	13 Apr 2024	10-K	16 Apr 2024	2023	FY
Q3 2023	237,649,403	+51,207,486	+27%	17 Oct 2023	10-Q	20 Nov 2023	2023	Q3
Q2 2023	227,649,403	+73,397,621	+48%	22 May 2023	10-Q	22 May 2023	2023	Q1
Q1 2023	223,649,403	+71,647,621	+47%	14 Apr 2023	10-K	17 Apr 2023	2022	FY
Q3 2022	186,441,917	+53,179,928	+40%	14 Nov 2022	10-Q/A	15 Nov 2022	2022	Q3
Q2 2022	154,251,782	+25,391,682	+20%	20 May 2022	10-Q	23 May 2022	2022	Q1
Q1 2022	152,001,782	+23,141,682	+18%	12 Apr 2022	10-K/A	19 Apr 2022	2021	FY
Q4 2021	136,178,104	+10,981,134	+8.8%	19 Nov 2021	10-Q	22 Nov 2021	2021	Q3
Q3 2021	133,261,989			20 Aug 2021	10-Q	23 Aug 2021	2021	Q2
Q2 2021	128,860,100	-2,229,478	-1.7%	24 May 2021	10-Q/A	02 Jun 2021	2021	Q1
Q1 2021	128,860,100	+421,460	+0.33%	13 Apr 2021	10-K/A	26 Apr 2021	2020	FY
Q4 2020	125,196,970			18 Nov 2020	10-Q/A	27 Nov 2020	2020	Q3
Q2 2020	131,089,578	+68,554,159	+110%	29 Jun 2020	10-Q/A	02 Jul 2020	2020	Q1
Q1 2020	128,438,640	+67,366,229	+110%	14 May 2020	10-K/A	20 May 2020	2019	FY
Q3 2019	63,035,419	+3,852,529	+6.5%	14 Nov 2019	10-Q	14 Nov 2019	2019	Q3
Q2 2019	62,535,419	+4,454,670	+7.7%	12 Aug 2019	10-Q	14 Aug 2019	2019	Q2
Q1 2019	61,072,411	+5,551,940	+10%	08 Apr 2019	10-K	08 Apr 2019	2018	FY
Q3 2018	59,182,890	+4,618,449	+8.5%	09 Nov 2018	10-Q	14 Nov 2018	2018	Q3
Q2 2018	58,080,749	+5,511,308	+10%	10 Aug 2018	10-Q/A	17 Aug 2018	2018	Q2
Q1 2018	55,520,471	+2,951,030	+5.6%	14 Mar 2018	10-K	15 Mar 2018	2017	FY
Q3 2017	54,564,441	+7,761,782	+17%	14 Nov 2017	10-Q	20 Nov 2017	2017	Q3
Q2 2017	52,569,441	+12,806,782	+32%	19 May 2017	10-Q/A	14 Sep 2017	2017	Q1
Q1 2017	52,569,441	+12,806,782	+32%	29 Mar 2017	10-Q/A	14 Sep 2017	2017	Q2
Q4 2016	51,492,659	+12,002,953	+30%	21 Nov 2016	10-Q/A	30 Nov 2016	2016	Q3
Q3 2016	46,802,659	+7,437,953	+19%	20 Aug 2016	10-Q/A	25 Aug 2016	2016	Q2
Q2 2016	39,762,659			23 May 2016	10-Q/A	26 May 2016	2016	Q1
Q1 2016	39,762,659	+5,744,659	+17%	13 Apr 2016	10-K/A	18 Apr 2016	2015	FY
Q4 2015	39,489,706			16 Nov 2015	10-Q	23 Nov 2015	2015	Q3
Q3 2015	39,364,706	+6,364,706	+19%	19 Aug 2015	10-Q/A	27 Aug 2015	2015	Q2
Q1 2015	34,018,000	+1,018,000	+3.1%	09 Apr 2015	10-K	14 Apr 2015	2014	FY
Q3 2014	33,000,000			30 Oct 2014	10-Q	14 Nov 2014	2014	Q3
Q2 2014	33,000,000	0	0%	14 Aug 2014	10-Q/A	26 Aug 2014	2014	Q2
Q1 2014	33,000,000	0	0%	30 Apr 2014	10-Q/A	18 Jun 2014	2014	Q1
Q4 2013	33,000,000			18 Nov 2013	10-Q	18 Nov 2013	2013	Q3
Q2 2013	33,000,000	0	0%	13 Aug 2013	10-Q	14 Aug 2013	2013	Q2
Q1 2013	33,000,000	0	0%	15 Apr 2013	10-K	15 Apr 2013	2012	FY
Q2 2012	33,000,000			30 Jun 2012	10-Q	19 Nov 2012	2012	Q3
Q1 2012	33,000,000			16 Apr 2012	10-K/A	01 May 2012	2011	FY
Q4 2011	33,000,000			15 Nov 2011	10-Q/A	21 Nov 2011	2011	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.